BioRender 图标

Enterocyte (epithelial���mesenchymal transition, stage 1)

Enterocyte (epithelial–mesenchymal transition, stage 1) - Editable icon of a columnar epithelial  cell with a few microvilli undergoing epithelial-mesenchymal transition, stage 1 of 4

[{"image":"https://icons.cdn.biorender.com/w75xh75/61f992d091f52d0028a55de5/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61f992d091f52d0028a55de5/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61f992d091f52d0028a55de3/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61f992d091f52d0028a55de3/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2527/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2527/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2528/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2528/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2529/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2529/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252a/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252a/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252b/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252b/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252c/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252c/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252d/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252d/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252e/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252e/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d252f/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d252f/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2530/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2530/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2531/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2531/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2532/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2532/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2533/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2533/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2534/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2534/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2535/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2535/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2536/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2536/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2537/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2537/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2538/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2538/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2539/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2539/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253a/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253a/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253b/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253b/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253c/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253c/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253d/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253d/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253e/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253e/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d253f/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d253f/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2540/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2540/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2541/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2541/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2542/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2542/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2543/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2543/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2544/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2544/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2545/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2545/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2546/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2546/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2547/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2547/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2548/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2548/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2549/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2549/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254a/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254a/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254b/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254b/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254c/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254c/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254d/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254d/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254e/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254e/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d254f/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d254f/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2550/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2550/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2551/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2551/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2552/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2552/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2553/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2553/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2554/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2554/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2555/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2555/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2556/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2556/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2557/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2557/5ca75af6117774330009985e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f94c5a4ff7a190d2558/5ca75af6117774330009985e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f94c5a4ff7a190d2558/5ca75af6117774330009985e.png"}]

使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right

intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,stem cell,healing,wound,fibrosis,metastasis,cancer,epithelial,mesenchymal,EMT,transition,epithelial to mesenchymal transition,oncology

查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Enterocyte (epithelial���mesenchymal transition, stage 1) icon JPEG

Enterocyte (epithelial���mesenchymal transition, stage 1) icon PNG

Enterocyte (epithelial���mesenchymal transition, stage 1) icon SVG

Enterocyte (epithelial���mesenchymal transition, stage 1) icon GIF

BioRender 图标常见问题解答

How are scientists using the Enterocyte (epithelial���mesenchymal transition, stage 1) icon in their work?

BioRender users often use the Enterocyte (epithelial���mesenchymal transition, stage 1) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Enterocyte (epithelial���mesenchymal transition, stage 1) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Enterocyte (epithelial���mesenchymal transition, stage 1) icon customizable in BioRender?

Most icons in BioRender, including the Enterocyte (epithelial���mesenchymal transition, stage 1) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Enterocyte (epithelial���mesenchymal transition, stage 1) icon for publication or presentations?

Yes, figures containing the Enterocyte (epithelial���mesenchymal transition, stage 1) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Enterocyte (epithelial���mesenchymal transition, stage 1) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Enterocyte (epithelial���mesenchymal transition, stage 1) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Enterocyte (epithelial���mesenchymal transition, stage 1) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon